G6/G7 Vs FreeStyle vs Medtronic CGM Accuracy Comparison 2026

You check your CGM. It says 61 mg/dL. You feel completely fine. You eat 20g of carbs just in case, and an hour later, you’re at 190.
Sound familiar? That’s not a device failure. That’s a CGM accuracy gap that nobody prepared you for.

Inaccurate readings cause real harm, over-corrected insulin doses, missed overnight lows, and false alarms that make you ignore the real ones. This CGM accuracy comparison covers every major sensor in 2026 with the correct clinical data, the latest updates, and one clear answer: which device is actually better for your situation.

What Is MARD & Why It Matters To You

MARD (Mean Absolute Relative Difference) is the standard measure of CGM accuracy. It’s the average percentage gap between your sensor reading and a true lab blood glucose value. Lower is better.

• Below 9%: Clinically excellent, safe for insulin dosing.
• 9-11%: Reliable for daily management.
• Above 12%: Acceptable but less reliable during rapid changes.

MARD is an average. A sensor scoring 9% overall can still miss badly during a fast overnight low. Always look at how a sensor performs at the extremes, not just the headline number.

Dexcom Accuracy in 2026: G6, G7, and G7 15-Day

Dexcom G6 (10 days):

• MARD: 9.0% vs lab reference.
• Factory calibrated, no fingerstick required.
• Real-time alerts, compatible with Tandem t:slim X2 and Omnipod 5.

Important: Dexcom officially stopped manufacturing the G6 on July 1, 2026. Remaining stock may still be available through pharmacies and DME distributors for a limited time, but availability is not guaranteed. Dexcom is urging all G6 users to upgrade to G7 or G7 15-Day now.

Most insurance plans that cover G6 will cover G7 at parity.

Dexcom G7 (10-day)

• MARD: 8.2%, clinically most accurate CGM in published 2026 data.
• 30-minute warm-up shortest of any CGM available today.
• All-in-one design, no separate transmitter.
• FDA-approved from age 2, the strongest pediatric accuracy data available.
• Compatible with Tandem t:slim X2, Omnipod 5, and iLet Bionic Pancreas.

Dexcom G7 15-Day (2026 upgrade)

• MARD: ~8.0%, same clinical accuracy as 10-day with 50% fewer sensor changes.
• Designed for adults 18 years and older.
• Apple Watch direct display, no phone required.
• Tandem t:slim X2 compatibility confirmed for 2026.
• Best choice for adults who want fewer disruptions without sacrificing accuracy

CGM Monitors carries Dexcom G7 sensors, starter kits, receivers, and G7 adhesive overlay patches, with insurance billing and free nationwide delivery.

FreeStyle Libre Accuracy: Libre 2 vs Libre 3 vs Libre 3 Plus

FreeStyle Libre 2 (14 days)

• MARD:  9.3%.
• Requires manual scanning, no automatic real-time readings.

No scan means no data. Users can be low for 20+ minutes before realizing it. In 2026, this is a safety limitation you don’t need to accept.

FreeStyle Libre 3

• MARD: 7.9% (lab condition), ~9-11% (real-world comparison).
• Fully automatic real-time readings every minute.
• World’s smallest CGM sensor, size of two stacked pennies.
• Strongest day-1 accuracy of any sensor, stabilizes faster after insertion than Dexcom or Guardian.
• 14-day wear, zero calibration required.

FreeStyle Libre 3 Plus (15-day)

• MARD:  8.2% (lab-based), matches Dexcom G7 in published head-to-head clinical studies.
• 15-day wear with accuracy maintained through the final day

2026 update: Abbott issued a Medical Device Correction for select Libre 3 and Libre 3 Plus sensor batches in late 2025 due to a manufacturing issue.

CGM Monitors stocks FreeStyle Libre 2, Libre 3, and Libre 3 Plus sensors, readers, monthly subscriptions, and adhesive patches with and without cutout.

Medtronic Accuracy: Guardian 4 vs Simplera Sync

Medtronic Guardian 4

• MARD: 8.7%, clinically strong, slightly behind G7 and Libre 3 Plus
• 7-day wear, no fingerstick calibration

The real advantage isn’t raw MARD, it’s deep integration with the MiniMed 780G closed-loop system. Sensor + pump + SmartGuard algorithm working together often outperforms any standalone accuracy number.

Medtronic Simplera Sync (FDA-approved 2025)

• MARD:  ~10.5% vs lab reference, highest variability of the major 2026 sensors
• 14 day wear, factory-calibrated.

Genuine strength: Detected 93% of low glucose events in the 2025 Freckmann head-to-head study, outperforming both G7 and Libre 3 for hypoglycemia detection

Known limitation: Reads consistently lower in the mid-to-high range, triggering unnecessary alarms for many users
CGM Monitors carries the Medtronic Simplera Sync and Guardian-compatible sensors for users within the Medtronic pump ecosystem.

Eversense 365: A Different Category

Eversense 365

• MARD:  8.5%.
• Wear time: 365 days.
• Calibration: Twice daily.

This isn’t just another CGM, it’s a different model entirely:

• One insertion per year.
• No weekly sensor changes.

Trade-off: Requires calibration and a minor procedure.

2026 CGM Accuracy Comparison Table

The Hidden Accuracy Problems Nobody Warns You About

• Compression lows during sleep: Rolling onto your sensor reduces local blood flow and drops the reading artificially. Move your sensor to the back of your upper arm to eliminate most false nighttime alarms.
• A peeling sensor gives wrong readings: When adhesive lifts, the sensor filament shifts under the skin and reads from a different glucose environment. CGM overlay patches are an accuracy tool, not just comfort. CGM Monitors carries patches for every major sensor.
• First-hour readings are least reliable: Every sensor is least accurate right after warm-up. Libre 3 stabilizes fastest; Guardian 4 takes the longest.
• Exercise increases lag time: Interstitial fluid lags blood glucose by 5-15 minutes. During intense activity, that gap widens. Always fingerstick-verify before dosing insulin mid-workout.

Which CGM Is Actually Better for You in 2026?

• On insulin, fear overnight lows → Dexcom G7 (10-day). Fastest warm-up, tightest lag during rapid drops, best real-time alert performance.
• Want fewer sensor changes with the same accuracy → Dexcom G7 15-Day. Adults 18+ get 15.5 days of G7-level accuracy with Apple Watch support. Biggest upgrade of 2026.
• Want the longest wear and near-identical accuracy to G7 → FreeStyle Libre 3 Plus. 15-day wear, smallest sensor, strongest day-1 stability. Ideal for T2D and anyone wanting simplicity.
• Using a MiniMed insulin pump → Guardian 4. The closed-loop system performance matters more than raw MARD. Don’t switch brands just for a marginal accuracy difference.
• Parent of a child with Type 1 → Dexcom G7 (10-day). FDA-cleared from age 2, the only option here.
• Want zero sensor changes all year → Eversense 365. One implant, one warm-up, 365 days of continuous readings. A completely new category, FDA-approved in 2026. Requires twice-daily fingerstick calibrations.
• Still using Dexcom G6 → Upgrade now. Manufacturing ended July 1, 2026. Stock is limited and not guaranteed. Your insurance most likely covers G7 at the same rate.

Conclusion:

CGM Monitors is a leading DME supplier in the USA, carrying genuine Dexcom, Abbott, Medtronic, and Omnipod CGM systems with a 94% customer satisfaction rating on Google. They offer free nationwide delivery, insurance billing, and monthly refills, so you can focus on managing your diabetes instead of managing your supply chain. Follow us on Facebook and Instagram for 2026 CGM updates, coverage tips, and device guides that actually reflect real-world accuracy and user experience.

Disclaimer:

This content is for informational purposes only and is not medical advice. CGM readings can vary and should not replace professional guidance. Always consult your healthcare provider and confirm critical readings before making treatment decisions.

Frequently Asked Questions